Growth and Funding Xeris Pharmaceuticals is a growth-oriented biopharmaceutical company with substantial funding of $200 million and annual revenues ranging from $100 million to $250 million, indicating capacity for expansion and investment in innovative product development.
Product Innovation The company's recent collaborations, such as the development of a glucagon product for proprietary pump technology with Beta Bionics, highlight opportunities to supply advanced drug delivery systems and related pharmaceuticals.
Strategic Leadership Recent hires and leadership changes, including new directors and senior medical executives, suggest an active strategy to strengthen global development and medical capabilities, opening avenues for partnerships in clinical and medical services.
Industry Engagement Participation in key industry conferences and awards, such as ADCES and Piper Sandler Healthcare Conference, presents opportunities for collaboration, visibility, and establishing relationships with healthcare providers and industry stakeholders.
Digital Infrastructure Utilization of advanced technology stacks like Veeva Vault and SAP Concur indicates a focus on digital transformation and efficient supply chain management, which can facilitate partnerships in healthcare IT solutions or supply chain optimization.
$100M$250M
$1B$10B
$10B
$10B
$10B
$10BXeris Pharmaceuticals, Inc. uses 8 technology products and services including Akamai, Veeva Vault, Microsoft, and more. Explore Xeris Pharmaceuticals, Inc.'s tech stack below.
| Xeris Pharmaceuticals, Inc. Email Formats | Percentage |
| FLast@xerispharma.com | 95% |
| Last@xerispharma.com | 3% |
| FMiddleLast@xerispharma.com | 1% |
| FirstL@xerispharma.com | 1% |
Pharmaceutical ManufacturingIllinois, United States201-500 Employees
We're a growth-oriented biopharmaceutical company improving patient lives by developing and commercializing advanced products across a range of therapies.
Company Overview
Funding & FinancialsXeris Pharmaceuticals, Inc. has raised a total of $200M of funding over 14 rounds. Their latest funding round was raised on Mar 06, 2024 in the amount of $200M.
Xeris Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $100M$250M
Funding & FinancialsXeris Pharmaceuticals, Inc. has raised a total of $200M of funding over 14 rounds. Their latest funding round was raised on Mar 06, 2024 in the amount of $200M.
Xeris Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $100M$250M
1-888-653-2347 
support@leadiq.com